MKI67 and breast carcinoma: The aim of this study was to correlate the immunohistochemical Ki-67 labelling index obtained using the two most reproducible methods from the SAKK 28/12 study with clinical data such as overall survival (OS) and the breast cancer-free interval (BCFI)27.